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Background. Throughout Asia, there is an unprecedented link between cholangiocarcinoma and infection with
the liver fluke Opisthorchis viverrini. Multiple processes, including chronic inflammation and secretion of parasite
proteins into the biliary epithelium, drive infection toward cancer. Until now, the mechanism and effects of parasite
protein entry into cholangiocytes was unknown.
Methods. Various microscopy techniques were used to identify O. viverrini extracellular vesicles (EVs) and their
internalization by human cholangiocytes. Using mass spectrometry we characterized the EV proteome and associated
changes in cholangiocytes after EV uptake, and we detected EV proteins in bile of infected hamsters and humans.
Cholangiocyte proliferation and interleukin 6 (IL-6) secretion was measured to assess the impact of EV internalization.
Results. EVs were identified in fluke culture medium and bile specimens from infected hosts. EVs internalized by
cholangiocytes drove cell proliferation and IL-6 secretion and induced changes in protein expression associated with
endocytosis, wound repair, and cancer. Antibodies to an O. viverrini tetraspanin blocked EV uptake and IL-6 secretion
by cholangiocytes.
Conclusions. This is the first time that EVs from a multicellular pathogen have been identified in host tissues. Our
findings imply a role for O. viverrini EVs in pathogenesis and highlight an approach to vaccine development for this
infectious cancer.
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The liver fluke Opisthorchis viverrini is classified as a
group 1 carcinogen by the International Agency for Re-
search on Cancer and is a major public health problem
in many parts of Southeast Asia. In northeast Thailand
alone, >8 million people harbor the parasite [1], owing
to traditional dietary preferences for eating uncooked
fish that harbor the infective stage of the fluke [2].
Upon ingestion of infected fish, the metacercariae ex-
cyst in the duodenum and migrate to the bile ducts of
the definitive host, where they feed on the biliary epithe-
lia. Infection is associated with a spectrum of hepato-
biliary abnormalities, including bile duct cancer or
cholangiocarcinoma (CCA) [2, 3]. The incidence of
CCA in northeast Thailand is substantially higher
than elsewhere in the world and associates strongly
with the prevalence of O. viverrini infection [4].
The mechanisms involved in liver fluke-driven tu-
morigenesis are multifactorial, with apparent roles for
(1) mechanical damage caused by parasites grazing on
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the biliary epithelium, (2) chronic immunopathologic processes
that are dominated by proinflammatory cytokines, such as inter-
leukin 6 (IL-6) [1], and (3) the active release of parasite-derived
excretory/secretory (ES) products into the bile ducts that drive un-
checked cell proliferation [2, 5–7]. Intriguingly, some of these ES
products have been identified inside cholangiocytes of experimen-
tally infected hamsters [6, 8, 9], akin to the intracellular presence
of the CagA protein from another carcinogenic pathogen,Helico-
bacter pylori [10]. Until now, the mechanisms by which liver fluke
ES proteins are internalized by cholangiocytes and the ramifica-
tions of this process for the host cell have remained unknown.
Recent reports have highlighted the presence of secreted extra-
cellular vesicles (EVs) from parasites of both unicellular [11, 12]
and multicellular (helminth) [13–15] origin, and they provide a
plausible explanation for the abundance in helminth ES products
of apparently “intracellular” proteins [16]. EVs are small, mem-
brane-enclosed structures that are released by many different
cell types [17, 18]. EVs from unicellular parasites have been
shown to influence host physiological processes, including immu-
nomodulation, and adherence and communication between host
and parasite [12, 19, 20]. A recent report described the uptake of
parasitic platyhelminth EVs by host cell lines in vitro, using low-
resolution fluorescence microscopy [13], but the molecular
impact of EV uptake on the recipient cell and the detection of
helminth EVs in vivo have, until now, not been reported.
Here we show thatO. viverrini secretes EVs that induce a proin-
flammatory/tumorigenic phenotype in human cholangiocytes.
We also show that cellular uptake of O. viverrini EVs can be
blocked by antibodies to an EV recombinant tetraspanin (TSP),
highlighting the potential usefulness of EV proteins in vaccines
to prevent fluke infection and associated cholangiocarcinogenesis.
MATERIALS AND METHODS
Ethics Statement
Hamsters were maintained at Khon Kaen University (KKU),
Thailand. The study was approved by the KKU Animal Ethics
Committee (AEKKU 55/2554). Human bile specimens were
collected under a protocol (HE 521209) approved by the
KKU Institutional Review Board.
Parasite Material, Isolation of ES Products, and EV Purification
Parasites were obtained from experimentally infected hamsters,
and ES products were isolated as described elsewhere [8]. EVs
were purified from ES products, using differential ultracentrifu-
gation according to a modified protocol [21]. Briefly, parasite
culture medium was centrifuged at 2000g for 30 minutes at
4°C to remove larger debris; supernatant was further cen-
trifuged at 15 000g for 30 minutes at 4°C. ES supernatants
were filtered using a 0.2-µm membrane (Schleicher and Schuell
Bioscience) and ultracentrifuged at 110 000g for 2 hours at
4°C. The pellet was washed in phosphate-buffered saline (PBS)
containing protease inhibitor cocktail (Roche) and ultracentri-
fuged for 1 hour. Crude pellet was resuspended in 200 µL of
PBS/protease inhibitor cocktail and stored at 4°C.
Preparation of EVs for Transmission Electron Microscopy
A total of 5 µL of purified EVs was applied to a carbon-formvar
coated grid and air dried. Grids were negatively stained in 2%
uranyl acetate for 15 seconds. Stained grids were viewed in a
JEM1011 transmission electron microscope (JEOL) equipped
with a Morada side-mounted digital camera (Olympus).
Fluorescence Labeling of EV Membranes
EVs were labeled with Alexa Fluor 488 5-SDP Ester (AF488;
Life Technologies) according to the manufacturer’s protocol.
EV pellets were resuspended in 400 µL of PBS and mixed
with 50 µg of AF488 for 1 hour at 4°C. The samples were col-
lected by ultracentrifugation at 110 000g for 2 hours to remove
excess dye, washed twice, and resuspended in 400 µL of PBS.
Cell Cocultures and Fluorescence Microscopy
To investigate internalization of EVs by mammalian cells, nor-
mal immortalized human cholangiocytes (H69) were grown to
80% confluence as described elsewhere [22]. Cells were starved
of fetal calf serum (FCS) overnight, incubated with AF488-
labeled EVs for 6 hours, and analyzed by fluorescence micros-
copy. Cell nuclei were stained with Hoechst dye and visualized
using an AxioImager M2 ApoTome fluorescence microscope
(Zeiss). Two technical and 2 biological replicates were per-
formed, and at least 5 fields were analyzed in each replicate.
Fluorescence was quantified using ImageJ.
Ultraresolution Microscopy
To convincingly demonstrate internalization of O. viverrini EVs
by cholangiocytes, we used 3-dimensional structured illumina-
tion microscopy (3D-SIM). H69 cholangiocytes were grown to
50% confluence and cocultured with AF488-labeled EVs or an
equivalent amount (based on fluorescence) of ES products (10
µg/mL) for up to 6 hours. Treated cells were fixed in 4% para-
formaldehyde, permeabilized in 0.1% Triton X-100 in PBS, and
stained with Alexa Fluor 568 Phalloidin (Life Technologies).
Specimens were mounted in 5% N-propyl gallate (Sigma),
and 3D-SIM was performed on isolated single cells using a
DeltaVision OMX 3D-SIM system (Applied Precision, GE
Healthcare). Solid-state lasers (405, 488, and 593 nm) provided
wide-field illumination, and multiple-channel images were cap-
tured simultaneously by using 3 pco.edge scientific complemen-
tary metal-oxide-semiconductor cameras with a 512 × 512 pixel
size. All data capture used a 60 × 1.4–numerical aperture oil ob-
jective and standard excitation (EX) and emission (EM) filter
sets (405 nm EX/419–465 nm EM, 488 nm EX/500–550 nm
EM, and 592.5 nm EX/608–648 nm EM). 3D-SIM images
were sectioned using a 125 nm Z-step size. Raw 3-phase images
were reconstructed as previously described [23]. Reconstructed
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images were rendered in 3 dimensions, using IMARIS version 7.
X (Bitplane Scientific).
Proteomic Analysis of EVs
Sample preparation for proteomic analysis was performed as
described previously [13]. Peptides were resuspended in 5% for-
mic acid and analyzed by liquid chromatography tandem mass
spectrometry (MS/MS). Ten microliters was injected onto a C18
trap column (Thermo Scientific Acclaim), flushed into an ana-
lytical column (Agilent), and eluted via a mobile phase gradient
of 5%–80% solvent B over 120 minutes. The eluted material was
directly applied to the nanospray source of a QSTAR Elite in-
strument (Applied Biosystems), and data analysis was conduct-
ed with Analyst 2.0 (Applied Biosystems).
iTRAQ Analysis
H69 cells were cocultured with the quantity of EVs that corre-
sponded to 1.2 µg/mL of ES protein in PBS for 30 minutes, 3
hours, and 16 hours. Cells were washed using PBS containing
protease inhibitor cocktail and lysed in 5 M urea, 2 M thiourea,
0.1% sodium dodecyl sulfate (SDS), 1% Triton X–100, and 40
mM Tris (pH 7.4). Each sample was ground with a TissueLyser
II (Qiagen) and centrifuged at 12 000g for 20 minutes. The pro-
tein supernatant was precipitated with cold methanol and cen-
trifuged at 8000g. Air-dried pellets were redissolved in 0.5 M
triethylammonium bicarbonate (TEAB)/0.05% SDS and then
centrifuged at 12 000g. Samples were resuspended in 0.5 M
TEAB prior to reduction, alkylation, digestion, and iTRAQ la-
beling (AB Sciex) and then were analyzed on a 5600 TripleTOF
mass spectrometer as described previously [24].
Bioinformatic Analysis of Protein Expression Data
For proteomic characterization of O. viverrini EV proteins, the
O. viverrini genome database [25]was interrogated using MAS-
COT (Matrix-Science), allowing 2 missed cleavages and mass
tolerance of 1.2 Da in MS mode and 0.8 Da on MS/MS product
ions. Probability (P < .05) of false-discovery rate (FDR) was cal-
culated for every search using the MASCOT decoy database fa-
cility. For iTRAQ, 2 biological and 2 technical replicates were
conducted. Database searches were performed against NCBInr
by using MASCOT, allowing 2 missed cleavages and a mass tol-
erance of 0.1 Da on MS and MS/MS modes. Results were vali-
dated using Scaffold v.4.2.1 (Proteome Software). Differentially
expressed (dysregulated) proteins were determined using a
Kruskal–Wallis test, and results are expressed in log2 ratios.
Only proteins whose expression level underwent a significant
(P < .05) log2 fold-change of >0.6 or ≤0.6 for upregulated and
downregulated proteins, respectively, were further considered.
Kyoto Encyclopedia of Genes and Genomes (KEGG) and Reac-
tome functional enrichment analyses for dysregulated proteins
were performed using KEGGMapper and DAVID [26]. Protein-
protein interaction analysis was performed using String [27].
Detection of EV Proteins in Bile of O. viverrini–Infected Humans
and Hamsters
Bile specimens were collected from O. viverrini–infected hu-
mans by aspiration of resected gallbladders and from experi-
mentally infected and uninfected hamsters (controls) by
puncture of the gallbladder from euthanized animals, and
EVs were isolated as described above. Selected reaction moni-
toring (SRM) was performed on a 5600 TripleTOF to identify
O. viverrini EV proteins in bile. All analyses were performed
using SRM-initiated IDA experiments, in which a SRM survey
scan triggered the acquisition of MS/MS spectra. Skyline 3.1 was
used to generate SRM transitions and for data analysis.
Cell Proliferation
H69 cholangiocytes were cultured as described above until 80%
confluent. Cells were starved of FCS overnight and cultured
with the amount of EVs that corresponded to 1.2 µg/mL of
ES protein over 72 hours at 37°C. Control cells were incubated
with 1.2 µg/mL of ES products (not ultracentrifuged) or, for the
negative control group, with 1.2 µg/mL bovine serum albumin
(BSA). Cell proliferation was assessed by measuring cell index
values in real time, using an xCELLigence SP system and E
plates (Acea). Three biological replicates were analyzed, and
2-way analysis of variance (ANOVA) was performed.
Blocking Internalization of EVs With A Recombinant O. viverrini
TSP-1
AF488-labeled EVs were incubated with mouse anti–O. viverrini
TSP-1 serum [28] or normal mouse serum at different dilu-
tions (1:2.5, 1:5, and 1:20) at room temperature for 1 hour.
EV-antibody complexes were added to H69 cells and cocultured
for 6 hours. Images were obtained using an ECLIPSE Ni-u con-
focal microscope (Nikon) at 60 times the original magnification.
Thirty fields from 2 biological replicates were analyzed, and
1-way ANOVAwas performed. Cell fluorescence was quantified
using ImageJ.
IL-6 Detection
H69 cholangiocytes were cultured as described above to moni-
tor cell proliferation over 24 hours. Culture media were collect-
ed and centrifuged at 2000g for 10 minutes to remove cell
debris. IL-6 levels were quantified using an IL-6 enzyme-linked
immunosorbent assay kit (R&D System) in accordance with the
manufacturer’s instructions. Three biological replicates were
analyzed, and statistical analysis was performed using 2-way
ANOVA.
RESULTS
Excretory/Secretory Products From O. viverrini Contain EV-Like
Vesicles
After filtration and ultracentrifugation of ES products from
adult O. viverrini, we identified microvesicular structures by
1638 • JID 2015:212 (15 November) • Chaiyadet et al
 at Jam
es Cook U
niversity on N
ovem
ber 2, 2015
http://jid.oxfordjournals.org/
D
ow
nloaded from
 
using negative staining in transmission electron microscopy
(Figure 1). These spherical vesicles had an external diameter
of 40–180 nm, resembling EVs recently reported from other
trematodes [13, 14].
Proteomic Analysis of O. viverrini EVs Reveals Conserved and
Novel Proteins
O. viverrini EVs were digested with trypsin and underwent LC-
MS/MS. We identified 108 different proteins (Supplementary
Table 1), 42 of which were homologous to mammalian EV pro-
teins in Exocarta [29], including proteins that are diagnostic of
mammalian exosomes, such as TSPs, HSP-70, and cytoskeletal,
regulatory, and trafficking proteins. Gene ontology analysis of
the proteins (Supplementary Figure 1) returned 212 biological
process terms. Pfam analysis identified proteins with an EF
hand domain as the most frequently represented (Supplemen-
tary Figure 1).
O. viverrini Exosome Proteins Are Identified in Bile Specimens
From Infected Hosts
SRM analysis confirmed the presence of specific EV proteins in
bile specimens obtained from O. viverrini–infected humans and
hamsters. Seven of the top 15 proteins identified in the EV
proteomic analysis (based on the number of peptides identified)
were successfully quantified (Supplementary Figure 2).
O. viverrini EVs Are Internalized by Human Cholangiocytes
We monitored the uptake of AF488-labeled EVs by human
cholangiocytes in vitro. Within 60 minutes, punctate fluores-
cent structures were detected, the number of which increased
markedly over 6 hours (Figure 2A). Cell fluorescence of all fields
from the 2 biological replicates revealed mean fluorescence cov-
erage (±SD) of 62.44% ± 9.52% and 90.57% ± 4.58% at 0.5
hours and 6 hours, respectively. 3D-SIM confirmed the intracel-
lular presence of AF488-labeled EVs within the cytoskeletal net-
work of well-separated individual cells, as evidenced by their
position between the basal and apical membranes outlined
with phalloidin (Figure 2B, 2C, and Supplementary Movie).
We attempted to colocalize EVs to defined organelles by
using specific fluorescent markers but did not observe colocal-
ization (not shown), suggestive of a cytoplasmic location.
O. viverrini EVs Promote Cell Proliferation and Stimulate Wound
Healing and Tumorigenic Pathways in Cholangiocytes
H69 cholangiocytes were incubated for 72 hours with (1) crude
ES products, (2) EVs purified from crude ES products, or (3) an
Figure 1. Extracellular vesicles (EVs) secreted by Opisthorchis viverrini. Transmission electron micrograph showing the presence of microvesicles after
ultracentrifugation of O. viverrini excretory/secretory products. EV-like microvesicles of 40–100 nm can be observed.
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irrelevant protein control, BSA. We chose BSA as a control rath-
er than EVs from another source because H69 cholangiocytes
produce (and take up) their own exosomes in culture [30]. ES
and EVs both induced significant (P < .05) cell proliferation
as compared to BSA-treated control cells (Figure 3). A total of
705 proteins containing at least 2 peptides were identified and
quantified with a 99.9% protein threshold and 1.2% FDR from
6863 unique peptides (peptide threshold, 95%; FDR, 0.82%)
from H69 cholangiocytes that were cocultured with EVs (Sup-
plementary Table 2); 396 proteins from cholangiocytes cocul-
tured with EVs were differentially expressed (P < .05, by the
Kruskal–Wallis test) and presented a fold-difference of ≥1.5
Figure 2. Internalization of Opisthorchis viverrini secreted extracellular vesicles (EVs) by human cholangiocytes. A, Fluorescence images of Alexa Fluor
488–labeled EVs (green) internalized by H69 cholangiocytes. Cholangiocytes internalized the EVs within 1 hour of coculture, and maximum internalization
was observed by 6 hours. Control cells were incubated with phosphate-buffered saline. Hoechst dye (blue) was used to label cell nuclei. B, Three-
dimensional structured illumination microscopy (3D-SIM) fluorescence image of the edge of a well-separated individual cholangiocyte after 6 hours incu-
bation with Alexa Fluor 488–stained EVs (green). Lateral (xy) overview of cell showing EVs present within the cytoskeletal actin network (red) of the cell. C,
Rendered axial (xz) view of the inset in panel A revealed EVs between the apical and basal surfaces of the cell that were stained by phalloidin (red).
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(log2 ≥0.6) at ≥1 time point (Supplementary Table 2). The
greatest changes in protein expression in EV-cocultured cells
as compared to control cells occurred after 3 hours, when 238
proteins (60.1%) were differentially expressed (fold-difference,
≥1.5 [log2 ≥0.6]) in cells incubated with EVs (Figure 4A).
A total of 274 proteins from EV-treated cells matched homol-
ogous proteins in the KEGG database associated with 186 dis-
tinct biological pathways; 171 of these proteins were assigned to
14 Reactome pathways (Supplementary Table 3). The 25 KEGG
and Reactome pathways associated with the largest numbers of
proteins differentially expressed after incubation with EVs are
shown in Figure 4B and 4C, respectively. The expression of
proteins linked to 4 pathways implicated in cancer and wound
healing was significantly modified by EVs (Figure 4B). Supple-
mentary Table 4 highlights all cholangiocyte proteins and
KEGG pathways related to cancer and wound healing and
their expression following co-culture with EVs. A total of 7
proteins involved in the phagosome pathway were differentially
expressed following exposure of human cholangiocytes to EVs
(Supplementary Figure 3 and Table 5).
When differentially expressed proteins were assigned to
Reactome pathways, those associated with apoptosis, regulation
of activated PAK-2p34 by proteasome, and Cdh1-mediated
degradation of Skp2 pathways were differentially regulated in
cholangiocytes cocultured with EVs (Figure 4C). Expression
of 17 proteins associated with apoptosis was regulated by
EVs, and protein-protein interactions revealed that the majority
of dysregulated cholangiocyte proteins formed a cluster belong-
ing to the proteasome complex (Supplementary Figure 4).
Uptake of EVs and Proinflammatory Cytokine Production by
Cholangiocytes Can Be Blocked With Antibodies to an O.
viverrini EV TSP
Because of the roles of TSPs in the formation of EVs by mam-
malian cells and their subsequent uptake by recipient cells [31]
and the recent identification of TSP-1 on the surface of O. viver-
rini [28], we explored the role of O. viverrini TSP-1 in the
uptake of EVs by cholangiocytes. Antiserum to recombinant
O. viverrini TSP-1 blocked the uptake of EVs by cholangiocytes
as compared to normal mouse serum (P range, <.0001 to <.001;
Figure 5). ES and EVs both stimulated the secretion of signifi-
cantly more IL-6 from cholangiocytes than did control cells in-
cubated with medium alone (P range, <.001 to <.01; Figure 6),
and IL-6 secretion was significantly reduced when EV internal-
ization was blocked by antiserum to O. viverrini TSP-1 (P < .05;
Figure 6).
DISCUSSION
While the mechanisms that drive chronic liver fluke infection
toward cancer are multifactorial, a pivotal role for fluke ES
products in promoting a tumorigenic phenotype has been dem-
onstrated [7]. The intracellular localization of O. viverrini ES
proteins in cholangiocytes of infected hosts has prompted spec-
ulation on the mechanisms underlying this process of parasite
protein internalization and its potential pathologic and carcino-
genic consequences [6, 7]. Herein we show that O. viverrini
secretes EVs that are internalized by human cholangiocytes in
vitro and trigger a cascade of inflammatory and protumorigenic
changes within the cell, thereby providing a plausible mecha-
nism by which ES proteins are taken up by biliary cells of infect-
ed hosts and contribute to the development of CCA in infected
individuals.
Investigations of the interactions between EVs derived from
single-celled parasites and the cells that they encounter in an in-
fected host have shed light on a novel means of host-parasite
cellular communication [11, 12]. Protozoan parasite EVs are
also capable of modulating proinflammatory immune responses
and inducing production of regulatory cytokines in recipient
cells [19]. EV production by helminth parasites, however, has
received considerably less attention. A seminal study recently
showed that the parasitic nematode Heligmosomoides polygyrus
secretes exosomes that contain microRNAs that suppress type 2
innate responses [15]. However, little is known about the
Figure 3. Opisthorchis viverrini extracellular vesicles (EVs) drive prolif-
eration of human cholangiocytes. O. viverrini EVs (open triangles) and ex-
cretory/secretory (ES) products (closed circles) promoted the proliferation
of human cholangiocytes. Asterisks represent the time point from which
cell growth remained significantly different between test and control
groups after each treatment. *P < .05. Abbreviation: BSA, bovine serum
albumin.
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Figure 4. Comparison of proteins that were significantly regulated and biological pathways regulated in cholangiocytes cocultured with Opisthorchis
viverrini extracellular vesicles (EVs). A, Heat map of the proteins from human cholangiocytes with a significant fold-regulation after the Kruskal–Wallis test
and that underwent a 2-fold change (log2 = 1.5) at at least one of the time points assessed after incubation with EVs from O. viverrini. B, Top 25 Kyoto
Encyclopedia of Genes and Genomes pathways regulated after incubation with EVs. C, Reactome pathways regulated after incubation with EVs. Pathways
that are involved in wound healing and cancer are indicated by red font. Abbreviations: HIV, human immunodeficiency virus; HTVL-1, human T-lymphotropic
virus type 1; mRNA, messenger RNA; UTR, untranslated region.
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production and particularly the biological effects of EVs from
parasitic flatworms (platyhelminths). EVs were reported in
the ES products from the flatworms Fasciola hepatica and Echi-
nostoma caproni [13] and, more recently, Dicrocoelium dendri-
ticum [14], and while the authors showed binding of fluke EVs
to cell lines, neither the functional implications nor in vivo ev-
idence of EV uptake by tissues of infected hosts were addressed.
We show here for the first time that helminth EVs are unequiv-
ocally internalized by host cells and that major EV proteins can
be detected in bile specimens from naturally infected humans
and experimentally infected hamsters. From proteomic analy-
ses, we identified 108 proteins from O. viverrini EVs, and
only a handful (13) had been previously identified in a proteo-
mic analysis of the ES products of the fluke [32].
Cholangiocytes line the bile ducts and provide the first line of
defense against pathogens in the biliary system. We show here
that O. viverrini EVs drive production of IL-6 from recipient
human cholangiocytes, implicating these EVs in the hepatic dis-
ease process. IL-6 has been associated with chronic periductal
fibrosis and CCA in patients with opisthorchiasis [33], and
IL-6 has been implicated in the maintenance of a chronic
inflammatory milieu that could lead to tumorigenesis [34].
O. viverrini EVs were also capable of driving proliferation of
cholangiocytes, a phenomenon that has been convincingly
Figure 5. Blockade of uptake of Opisthorchis viverrini extracellular vesicles (EVs) by antibodies to recombinant O. viverrini tetraspanin 1 (TSP-1). Mouse
antibodies raised to recombinant O. viverrini TSP-1 blocked the uptake of Alexa Fluor 488-labeled O. viverrini EVs by H69 cholangiocytes. A and B, Fluo-
rescence micrographs of internalized EVs co-cultured with H69 cholangiocytes in the presence of anti–O. viverrini TSP-1 serum (A) or normal mouse serum
(NMS; B) at different dilutions. Anti–O. viverrini TSP-1 significantly reduced the binding and internalization of EVs at all serum dilutions when measured as
fluorescence intensity (C), compared with NMS (D). ***P < .001 and ****P < .0001. Abbreviation: CTCF, corrected total cell fluorescence.
Liver Fluke Extracellular Vesicles • JID 2015:212 (15 November) • 1643
 at Jam
es Cook U
niversity on N
ovem
ber 2, 2015
http://jid.oxfordjournals.org/
D
ow
nloaded from
 
documented in the hamster infection model [35].This relentless
cell proliferation, coupled with other carcinogenic insults such
as chronic immunopathology and elevated intake of dietary ni-
trosamines [2], culminates in the establishment of an environ-
ment that is conducive to malignant changes.
Uptake of EVs by cholangiocytes resulted in dysregulated ex-
pression of proteins with documented roles in wound healing
and cancer. Indeed, wound repair has long been implicated in tu-
morigenesis, and there are striking histological and molecular
similarities between tumor stroma and wounded tissues [36].
Nineteen KEGG pathways related to cancer and wound healing
were affected by EVs in human cholangiocytes. Among the pro-
teins significantly regulated, we found different tropomyosin iso-
forms, PAK-2 and the tight junction protein ZO-2. PAK-2 is an
important kinase that mediates tumor cell invasion [37].We also
noted that PAK-2 could play an important role in tumor progres-
sion by interacting with different components of the proteasome
and with vimentin, a protein involved in maintaining cellular in-
tegrity and providing resistance against stress in several epithelial
cancers [37]. Moreover, tight junction proteins play important
roles in cell-cell junction assembly and organization, and they
are upregulated during cell proliferation and wound healing [38].
Other important cholangiocyte proteins underwent dysregu-
lated expression after coculture with EVs, notably proteins
involved in the proteasome complex. Most of the proteins in-
volved in this complex were upregulated in cholangiocytes
exposed to EVs and are known to interact with other proteins
involved in cancer and wound healing processes. The protea-
some complex regulates directly or indirectly many important
cellular processes and has been suggested as a therapeutic target
for cancer [39, 40].
EV uptake by dendritic cells can be blocked with antibodies to
EV TSPs [41].TSPs are thought to be involved in the regulation of
protein assembly andmicroRNA recruitment in mammalian exo-
somes [31] and influence cell selectivity [42]. Our findings high-
light an important role for TSP-1 in O. viverrini EV uptake by
cholangiocytes. Although TSPs are found on the surface mem-
branes of all exosomes, their discovery here is particularly perti-
nent owing to their abundance on the surface membranes of
parasitic helminths [43] and their importance in the development
of the O. viverrini tegument [28]. TSPs are efficacious helminth
vaccine antigens [44–46], and our findings here suggest that the
mechanism of vaccine efficacy is linked to interruption of parasite
EV uptake by recipient host cells in vivo and subsequent disrup-
tion of key physiological (and pathological) processes.
Our study describes for the first time the release of EVs in the
secreted products of the carcinogenic liver fluke, O. viverrini,
and highlights the role of fluke EVs in promoting an inflamma-
tory yet simultaneously modulatory (wound healing) environ-
ment that ultimately facilitates the development of biliary
cancer. Our findings do, however, offer hope for the eventual
control of this debilitating neglected tropical disease by high-
lighting a key physiological process that can be potentially inter-
rupted via subunit vaccines targeting key EV surface molecules.
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